DNA Genotek Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
153
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$50.5M
DNA Genotek General Information
Description
Developer of oral fluid sample collection, stabilization and preparation products created for molecular diagnostic applications. The company offers deoxyribonucleic acid and ribonucleic acid collection kits, stabilization reagents, expression profiling, preparation reagents, nucleic acid extraction, single nucleotide polymorphisms genotyping and bioinformatic analysis, enabling physicians to collect samples in the least invasive ways and reduce pain for patients.
Contact Information
Website
www.dnagenotek.com(Operating Subsidiary)
Corporate Office
- 3000 - 500 Palladium Drive
- Ottawa, Ontario K2V 1C2
- Canada
Corporate Office
- 3000 - 500 Palladium Drive
- Ottawa, Ontario K2V 1C2
- Canada
DNA Genotek Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 30-Sep-2011 | $50.5M | Completed | Profitable | ||
1. Early Stage VC | 01-Jan-2001 | Completed | Startup |
DNA Genotek Comparisons
Industry
Financing
Details
DNA Genotek Competitors (2)
One of DNA Genotek’s 2 competitors is PreAnalytiX, a Corporate Backed or Acquired company based in Hombrechtikon, Switzerland.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
PreAnalytiX | Corporate Backed or Acquired | Hombrechtikon, Switzerland | ||||
Biocept | Formerly VC-backed | San Diego, CA |
DNA Genotek Patents
DNA Genotek Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2022291168-A1 | Low ph composition and method for stabilizing nucleic acids in biological samples | Pending | 08-Jun-2021 | ||
CA-3222133-A1 | Low ph composition and method for stabilizing nucleic acids in biological samples | Pending | 08-Jun-2021 | ||
EP-4352249-A1 | Low ph composition and method for stabilizing nucleic acids in biological samples | Pending | 08-Jun-2021 | ||
US-20240271184-A1 | Low ph composition and method for stabilizing nucleic acids in biological samples | Pending | 08-Jun-2021 | ||
US-D967455-S1 | Tube and cap spacer | Active | 21-Jan-2021 |
DNA Genotek Signals
DNA Genotek Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Purple Angel | Angel Group | Minority |
DNA Genotek FAQs
-
When was DNA Genotek founded?
DNA Genotek was founded in 1998.
-
Where is DNA Genotek headquartered?
DNA Genotek is headquartered in Ottawa, Canada.
-
What is the size of DNA Genotek?
DNA Genotek has 153 total employees.
-
What industry is DNA Genotek in?
DNA Genotek’s primary industry is Surgical Devices.
-
Is DNA Genotek a private or public company?
DNA Genotek is a Private company.
-
What is the current valuation of DNA Genotek?
The current valuation of DNA Genotek is
. -
What is DNA Genotek’s current revenue?
The current revenue for DNA Genotek is
. -
Who are DNA Genotek’s investors?
Purple Angel has invested in DNA Genotek.
-
Who are DNA Genotek’s competitors?
PreAnalytiX and Biocept are competitors of DNA Genotek.
-
When was DNA Genotek acquired?
DNA Genotek was acquired on 30-Sep-2011.
-
Who acquired DNA Genotek?
DNA Genotek was acquired by Orasure Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »